Develops IVD tests for screening;therapeutic decision making;and follow-up care in cancer diagnostics
oncgnostics GmbH has raised €1.0M across 2 funding rounds from 2 investors, most recently a round in Sep 2023. Based in Germany; founded 2012; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-09-11 | Other | — | Grande Bio-tech Co. | View deal → |
| 2017-02-01 | Early VC | €1.0M | bm-t Beteiligungsmanagement Thüringen GmbH | View deal → |
